Type 1 Diabetes Study-VX20-880-101

The purpose of this study is to evaluate the safety, tolerability, and efficacy of an investigational islet cell infusion in individuals aged 18 to 65 with type 1 diabetes with severe low blood sugar (hypoglycemia) and impaired hypoglycemic awareness. The goal of this infusion is to provide replacement cells for the ones that have been lost or do not work properly in people with diabetes. For more information, please respond to this ad and the study team will reach out to you.

Sponsor

Vertex Pharmaceuticals Incorporated (Vertex)

Principle Investigator

Trevor Reichman

Researchers

Honey Lad
erin winter

Co-investigators

Bruce Perkins

Recruiting time left

Days

Hours

Minutes

Seconds

Contribute

Participating in research not only gives you access to innovative treatments, but also allows you to contribute to the discovery of new therapies.

Commitment

42

Visits

90+ mins

Duration

flex

Frequency

Locations

Home Visit

Home visits bring the study straight to the participant’s home for their convenience.

In-Clinic

This indicates a physical location that participants would be required to travel to for the study activities.

Clinics

< View All Studies